Purpose This study aimed to compare the performance of 68 Ga-labelled fibroblast
activating protein inhibitor (FAPI) PET and 18 F-FDG PET for imaging of hepatic tumours …

Cholangiocarcinomas are a heterogeneous group of highly aggressive cancers that may
arise anywhere within the biliary tree. There is a wide geographical variation with regards to …

Background: Liquid biopsy is a collective term that refers to the analysis of tumor-derived
biomarkers isolated from biological fluids of cancer patients. Recently, many authors …

Background Patients with malignant hilar biliary strictures can suffer from obstructive
jaundice. Controversy remains on the optimal approach to obtain preoperative or palliative …

The incidence of primary liver tumors, hepatocellular carcinoma (HCC), intrahepatic
cholangiocellular carcinoma (ICC), and combined HCC/ICC (cHCC/CC) is increasing. For …

Liver cancer, comprising hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA),
is a leading cause of cancer-related deaths worldwide. The liver is a primary metabolic …

Background: Intrahepatic cholangiocarcinoma (ICC) represents an aggressive carcinoma
with a dismal prognosis. For resection specimens, histopathological prognosticators are …

Background. It was reported that systemic immune inflammation index (SII) was related to
poor prognosis in a variety of cancers. We aimed to investigate the ability of the prognostic …

Liver cancer ranks sixth globally in diagnoses and second in cancer-related deaths.
Cholangiocarcinoma (CCA), a relatively rare cancer originating from bile duct epithelium …

Selective internal radiation therapy (SIRT) is a therapeutic option for primary and metastatic
liver tumors. Microspheres containing Yttrium 90, a beta-emitting radionuclide, are …